Bergamot Extract: The Complete Supplement Guide
On this page
Quick Reference Card
Attribute
Common Name
- Detail
- Bergamot Extract (Citrus Bergamot, BPF)
Attribute
Other Names / Aliases
- Detail
- Bergamot Polyphenol Fraction (BPF), Citrus bergamia extract, Bergamonte, Bergavit
Attribute
Category
- Detail
- Herbal Extract / Citrus Polyphenol
Attribute
Primary Forms & Variants
- Detail
- Bergamot Polyphenol Fraction (BPF, standardized to 38% polyphenols); BPF Phytosome (enhanced bioavailability via phospholipid complexing); Bergamot juice extract; Standardized flavonoid extract (16% neoeriocitrin, 47% neohesperidin, 37% naringin)
Attribute
Typical Dose Range
- Detail
- 500-1,500 mg/day (BPF); 150 mg/day (standardized flavonoid extract); up to 1,300 mg twice daily in clinical research
Attribute
RDA / AI / UL
- Detail
- No RDA, AI, or UL established. Not classified as an essential nutrient.
Attribute
Common Delivery Forms
- Detail
- Capsules, tablets
Attribute
Best Taken With / Without Food
- Detail
- Most sources suggest taking 20-30 minutes before meals for optimal interaction with dietary fat metabolism
Attribute
Key Cofactors
- Detail
- Vitamin C (co-administered in several clinical trials at 50 mg); may complement statin therapy (under medical supervision)
Attribute
Storage Notes
- Detail
- Store in a cool, dry place away from direct sunlight. Keep container tightly sealed.
Overview
The Basics
Bergamot extract comes from the bergamot orange (Citrus bergamia), a citrus fruit grown almost exclusively in the Calabria region of southern Italy. If you have ever sipped Earl Grey tea, you have tasted bergamot: the distinctive floral-citrus flavor comes from the fruit's essential oil. But bergamot extract used as a supplement is something quite different from the flavoring. It is a concentrated preparation drawn from the juice, pith, and rind of the fruit, standardized for its polyphenol content.
What makes bergamot stand out among citrus fruits is its unusually high concentration of specific polyphenols, particularly neoeriocitrin, naringin, and neohesperidin. These compounds have attracted attention for their effects on cholesterol metabolism. In Italian folk medicine, bergamot has been used for centuries to treat fever, sore throat, and infections [1]. More recently, clinical researchers have turned their attention to how these polyphenols influence blood lipid levels.
The primary reason most people consider bergamot extract today is cholesterol management. Several clinical trials have shown that bergamot polyphenol fraction (BPF) can reduce total cholesterol and LDL ("bad" cholesterol) in people with elevated levels. Some of these trials have also observed improvements in triglycerides and HDL ("good" cholesterol). This has made bergamot a popular option among individuals seeking alternatives to statin medications or looking for complementary support alongside pharmaceutical treatment [1][2].
The Science
Citrus bergamia Risso et Poiteau belongs to the Rutaceae family and is cultivated primarily along the Ionian coast of Calabria, Italy, where the unique microclimate supports its growth. The fruit is a hybrid, likely derived from sour orange (Citrus aurantium) and lemon (Citrus limon), although its precise origin remains debated [1].
The bergamot fruit contains a distinctive phytochemical profile. Beyond the essential oil components (monoterpenes, linalool, linalyl acetate), the juice and albedo yield high concentrations of flavanone glycosides (neoeriocitrin, naringin, neohesperidin), flavone O-glycosides (brutieridin, melitidin), and C-glucoside flavonoids (vicenin-2, lucenin-2). The presence of brutieridin and melitidin, which contain 3-hydroxy-3-methylglutaryl (HMG) moieties structurally analogous to statins, is particularly notable and provides the theoretical basis for bergamot's cholesterol-modulating activity [1][3].
A 2022 network meta-analysis comparing ten lipid-lowering nutraceuticals ranked bergamot as the most effective for LDL-C reduction, with a weighted mean difference of -46.8 mg/dL, surpassing berberine, garlic, green tea extract, plant sterols, policosanols, and silymarin [4]. A separate meta-analysis of randomized controlled trials reported significant reductions in TC (WMD: -63.60 mg/dL), TG (WMD: -74.72 mg/dL), and LDL-C (WMD: -55.43 mg/dL), with a modest increase in HDL-C (WMD: +5.78 mg/dL) [5]. These data position bergamot extract among the more evidence-supported nutraceuticals for lipid management, though the clinical trial base remains relatively small and is concentrated among Italian research groups.
Chemical & Nutritional Identity
Property
Botanical Name
- Value
- Citrus bergamia Risso et Poiteau
Property
Family
- Value
- Rutaceae
Property
Key Polyphenols
- Value
- Neoeriocitrin, naringin, neohesperidin, brutieridin, melitidin
Property
C-Glucoside Flavonoids
- Value
- Vicenin-2, lucenin-2, stellarin-2, scoparin, orientin 4'-methyl ether
Property
HMG-Containing Compounds
- Value
- Brutieridin, melitidin (structural analogues to statins)
Property
CAS Number
- Value
- Not applicable (complex botanical extract)
Property
PubChem CID
- Value
- Not applicable (mixture)
Property
Category
- Value
- Citrus polyphenol extract
Property
RDA / AI / UL
- Value
- Not established
Bergamot extract is typically standardized by its total polyphenol content, with 38% polyphenols being a common benchmark in clinical trials. The key active constituents are flavanone glycosides, with neoeriocitrin, naringin, and neohesperidin serving as marker compounds for quality control. Brutieridin and melitidin are unique to bergamot among commercially available citrus fruits and contain HMG moieties that have been proposed as the basis for statin-like activity [1][3].
A standardized extract used in one major clinical trial specified 16% neoeriocitrin, 47% neohesperidin, and 37% naringin as marker compounds [6]. Another common formulation (BPF) targets 38% total polyphenolic content with ascorbic acid added as a stabilizer [7].
Mechanism of Action
The Basics
Bergamot extract works in your body primarily by influencing how your liver handles cholesterol. Think of it as pressing on multiple levers of the cholesterol system simultaneously, rather than just one.
The most important thing bergamot polyphenols do is activate a cellular energy sensor called AMPK. When AMPK is switched on, it tells your liver to slow down cholesterol production and increase its ability to clear LDL cholesterol from your blood. This is similar in principle to how statin medications work, though the specific pathways are not identical [1][7].
Bergamot also appears to help protect your cholesterol particles from oxidation. Oxidized LDL is a particularly harmful form of cholesterol that contributes to plaque buildup in your arteries. By reducing oxidation, bergamot may help keep your cardiovascular system healthier beyond simply lowering the numbers on a blood test [1][8].
A third effect involves how your body processes dietary fats. Bergamot polyphenols can interfere with an enzyme called pancreatic cholesterol ester hydrolase (pCEH), which breaks down dietary cholesterol so it can be absorbed. By slowing this enzyme, bergamot may reduce how much cholesterol your body absorbs from food [9].
The Science
Bergamot polyphenols exert their biological effects through several complementary mechanisms [1][3][7]:
AMPK Activation: Naringin promotes phosphorylation of AMP-activated protein kinase (AMPK) at threonine-172 in hepatocytes, altering the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), sterol regulatory element-binding proteins (SREBPs), and low-density lipoprotein receptor (LDLR). Down-regulation of SREBPs and PCSK9 coupled with increased LDLR expression enhances hepatic LDL clearance [10]. Additionally, bergamot flavonoids activate sirtuin-1 and AMPK-alpha, central regulators of cellular energy homeostasis [8].
Statin-Like HMG-CoA Reductase Inhibition (Proposed): Brutieridin and melitidin contain 3-hydroxy-3-methylglutaryl moieties structurally analogous to the pharmacophore of statin drugs. Computational modeling suggests these compounds bind HMG-CoA reductase at Arg590, Ser684, Asp690, Lys692, and Lys735 residues [3][11]. However, definitive in vitro validation of direct HMG-CoA reductase inhibition by intact bergamot flavonoids has not been established.
Anti-Oxidative Effects: Naringin, neoeriocitrin, and rutin demonstrate antioxidant activity, reducing LDL oxidation in multiple in vitro models (DPPH, beta-carotene-linoleic acid, superoxide scavenging) [12]. A 2024 RCT demonstrated that bergamot extract significantly reduced oxidized LDL (ox-LDL) by 2.0% and increased paraoxonase-1 (PON1) activity by 6.5% over 4 months [8].
pCEH Inhibition: Bergamot polyphenol fraction inhibits pancreatic cholesterol ester hydrolase (pCEH) activity, reducing the hydrolysis of sterol esters into sterols and fatty acids, thereby limiting intestinal cholesterol absorption [9].
Anti-Inflammatory Activity: Bergamot flavonoids reduce LPS-induced inflammatory response through SIRT1-mediated NF-kappaB inhibition in monocytes, suppressing pro-inflammatory cytokine production [13].
Anti-Atherogenic Effects: In animal models, naringin significantly reduced fatty streak formation, macrophage infiltration in endothelial cells, and ICAM-1 elevation. Pre-treatment with bergamot extract reduced neointima formation following vascular injury [1][14].
Absorption & Bioavailability
The Basics
One of the practical challenges with bergamot extract is that, like many plant polyphenols, it is not absorbed very efficiently by the body. Your digestive system breaks down and metabolizes a significant portion before it reaches your bloodstream. This is why standardized, concentrated extracts are used in supplements rather than simply drinking bergamot juice.
Taking bergamot before meals appears to be the preferred approach in clinical settings. The polyphenols may interact with dietary fats during digestion, which could influence both absorption and the supplement's effects on cholesterol metabolism. Most clinical trials have instructed participants to take bergamot 20 to 30 minutes before eating [7].
Some manufacturers have developed phytosome formulations, where bergamot polyphenols are complexed with phospholipids to enhance absorption. In one clinical trial, a BPF phytosome formulation at 500 mg twice daily produced results comparable to standard BPF at 650 mg twice daily, suggesting improved bioavailability [7]. Preclinical research on encapsulated BPF formulations has shown substantially higher plasma levels of polyphenol metabolites compared to standard preparations [15].
The Science
The bioavailability of bergamot polyphenols follows the general pharmacokinetic profile of citrus flavanone glycosides. Following oral administration, naringin and neohesperidin undergo hydrolysis by intestinal microflora to release their respective aglycones (naringenin and hesperetin), which are then absorbed across the intestinal epithelium and further conjugated by phase II enzymes [7][15].
A 2025 preclinical study demonstrated that a novel encapsulated BPF formulation (BPFencap, using micronized BPF in hybrid phospholipid systems with citrus albedo fibers) substantially increased plasma AUC of polyphenol metabolites compared to both standard BPF and micronized BPF preparations across all time points measured over 6 hours [15]. This suggests that formulation technology significantly influences the systemic availability of bergamot polyphenols.
Research & Clinical Evidence
The Basics
The evidence for bergamot extract centers primarily on cholesterol and cardiovascular health. Multiple clinical trials, including randomized controlled trials, have tested bergamot polyphenol fraction in people with elevated cholesterol, and the results have been consistently encouraging for lipid management.
The largest and most robust trial enrolled 237 people and found that bergamot reduced total cholesterol by 20 to 31% and LDL cholesterol by 23 to 39%, depending on dose. Triglycerides dropped by 28 to 41% in people who had elevated levels, and HDL ("good" cholesterol) increased by 16 to 39%. These are substantial effects that compare favorably to some prescription medications [7].
An interesting aspect of the evidence is the finding that bergamot may benefit people who cannot tolerate statin medications. In a subset of the large trial, 32 statin-intolerant patients who took 1,500 mg of bergamot daily experienced significant cholesterol reductions without the muscle pain and other side effects that had forced them to stop their statins [7].
A 6-month study also found that bergamot reduced the size of carotid artery plaque (measured by carotid intima-media thickness), moving from 1.2 mm to 0.9 mm. This suggests that the benefits may extend beyond simply changing numbers on a blood test to influencing actual cardiovascular structure [6].
The evidence is promising but comes with important caveats. Most studies have relatively small sample sizes. Several of the most-cited trials come from the same research group in Italy. Longer and larger independent trials are needed to confirm these findings and establish long-term safety [2][5].
The Science
Meta-Analytic Evidence: A 2022 systematic review and meta-analysis of RCTs reported that bergamot supplementation significantly decreased TC (WMD: -63.60 mg/dL, 95% CI: -78.03 to -49.18, p < .001), TG (WMD: -74.72 mg/dL, 95% CI: -83.58 to -65.87, p < .001), LDL-C (WMD: -55.43 mg/dL, 95% CI: -67.26 to -43.60, p < .001), and increased HDL-C (WMD: +5.78 mg/dL, 95% CI: 3.27 to 8.28, p < .001) [5].
A network meta-analysis comparing 10 nutraceuticals ranked bergamot and red yeast rice as the most effective for LDL-C and TC reduction. Bergamot achieved an LDL-C reduction of -1.21 mmol/L (-46.8 mg/dL), the largest among all tested compounds [4].
A 2019 systematic review of 12 studies found that 75% showed significant decreases in TC (12.3-31.3%), LDL-C (7.6-40.8%), and TG (11.5-39.5%). A dose-dependent effect and possible synergistic effect with statins were noted, though study quality was variable [2].
Key Clinical Trials:
Mollace et al. (2011): RCT, n=237. BPF 500 mg or 1,000 mg daily for 30 days. TC reduced 20-30.9%, LDL-C reduced 23-38.6%, HDL-C increased 25.9-39%. Glucose reduced 18.9-22.4% in hyperglycemic subgroup. 32 statin-intolerant patients on 1,500 mg BPF showed TC -25% and LDL -27.6% without statin toxicity recurrence [7].
Toth et al. (2016): Open-label, n=80. 150 mg bergamot flavonoids (Bergavit R) daily for 6 months. TC -12%, LDL -17%, TG -16%, HDL +8%. Significant shift from small dense LDL (LDL-3, -4, -5) to large buoyant LDL (LDL-1). Carotid intima-media thickness reduced from 1.2 to 0.9 mm (p < 0.0001) [6].
Nobile et al. (2024): RCT, double-blind, n=64. 150 mg/day standardized flavonoids for 4 months. TC -8.8%, LDL-C -11.5%, ox-LDL -2.0%, PON1 +6.5%. HDL-C +5.5% trending toward significance. Good tolerability confirmed [8].
Gliozzi et al. (2013): Parallel group, n=77. BPF 1,000 mg + ascorbic acid 50 mg daily for 30 days. BPF comparable to rosuvastatin 10 mg for TC and LDL reduction. BPF + rosuvastatin 10 mg combination achieved reductions similar to rosuvastatin 20 mg alone, with improved endothelial markers [16].
Mollace et al. (2018): RCT, double-blind, n=60. BPF 650 mg twice daily vs. BPF Phyto 500 mg twice daily for 30 days. Both formulations reduced TC, LDL, TG, and glucose by comparable magnitudes. BPF Phyto showed slightly greater HDL increase [7].
Athletic Performance: A 2025 pilot study in 90 male cyclists found that Bergamot Polyphenolic Fraction Gold (BPFG) combined with L-citrulline produced synergistic improvements in nitric oxide release, reactive hyperemia index, and VO2 max over 3 months of supplementation [17].
Evidence & Effectiveness Matrix
Category
Heart Health
- Evidence Strength
- 8/10
- Reported Effectiveness
- 7/10
- Summary
- Multiple RCTs and meta-analyses demonstrate significant reductions in TC, LDL-C, and TG. Bergamot ranked most effective nutraceutical for LDL reduction in a network meta-analysis. Community reports are generally positive but variable.
Category
Blood Pressure
- Evidence Strength
- 3/10
- Reported Effectiveness
- 4/10
- Summary
- Limited clinical data suggesting modest blood pressure effects. Insufficient community data.
Category
Inflammation
- Evidence Strength
- 5/10
- Reported Effectiveness
- 4/10
- Summary
- In vitro evidence of NF-kappaB inhibition and anti-inflammatory cytokine suppression. Limited human outcome data on inflammatory markers.
Category
Side Effect Burden
- Evidence Strength
- 7/10
- Reported Effectiveness
- 7/10
- Summary
- Clinical trials consistently report good tolerability. Community reports are largely favorable, with bergamot perceived as well-tolerated compared to statins.
Category
Nausea & GI Tolerance
- Evidence Strength
- 5/10
- Reported Effectiveness
- 5/10
- Summary
- Gastric pyrosis (heartburn) reported in some participants at higher doses but did not lead to discontinuation.
Category
Sleep Quality
- Evidence Strength
- 2/10
- Reported Effectiveness
- 3/10
- Summary
- No clinical evidence for sleep effects. One anecdotal community report of insomnia.
Category
Treatment Adherence
- Evidence Strength
- 5/10
- Reported Effectiveness
- 6/10
- Summary
- Simple capsule dosing supports adherence. Community reports indicate most users maintain the regimen without difficulty.
Category
Energy Levels
- Evidence Strength
- 2/10
- Reported Effectiveness
- 4/10
- Summary
- No clinical evidence for energy effects. Not a reported outcome in community data.
Categories not scored (insufficient data): Fat Loss, Muscle Growth, Weight Management, Appetite & Satiety, Food Noise, Focus & Mental Clarity, Memory & Cognition, Mood & Wellbeing, Anxiety, Stress Tolerance, Motivation & Drive, Emotional Aliveness, Emotional Regulation, Libido, Sexual Function, Joint Health, Pain Management, Recovery & Healing, Physical Performance, Gut Health, Digestive Comfort, Skin Health, Hair Health, Heart Rate & Palpitations, Hormonal Symptoms, Temperature Regulation, Fluid Retention, Body Image, Immune Function, Bone Health, Longevity & Neuroprotection, Cravings & Impulse Control, Social Connection, Withdrawal Symptoms, Daily Functioning.
Benefits & Potential Effects
The Basics
The primary benefit that draws most people to bergamot extract is its effect on cholesterol levels. Clinical trials have consistently shown reductions in total cholesterol and LDL cholesterol, with the most robust trial reporting LDL reductions of 23 to 39% depending on dose. For context, that range overlaps with the lower end of what some prescription cholesterol medications can achieve [2][7].
Beyond just lowering LDL, bergamot may improve the quality of your cholesterol profile. One study showed that bergamot shifted LDL particles from the small, dense type (considered more harmful) to the larger, more buoyant type (considered less harmful). This is a meaningful distinction because particle size influences how likely cholesterol is to contribute to arterial plaque [6].
Bergamot has also shown promise for blood sugar management. In patients who had both high cholesterol and elevated blood sugar, bergamot reduced fasting glucose by 19 to 22%. This is particularly relevant because high cholesterol and insulin resistance often occur together, and addressing both simultaneously can be valuable [7].
Another notable benefit is the potential for complementary use alongside statin medications. In one study, combining bergamot with a low-dose statin (rosuvastatin 10 mg) achieved cholesterol reductions similar to doubling the statin dose, which could allow patients to maintain the benefits of their medication while using a lower dose [16].
The Science
The evidence base supports several distinct benefit pathways [1][2][5][7]:
Lipid Modification: Across multiple clinical trials, BPF demonstrates consistent reductions in TC (12-31%), LDL-C (8-39%), and TG (12-41%), with increases in HDL-C (6-39%). The magnitude of effect is dose-dependent, with 1,000 mg daily producing substantially larger reductions than 500 mg or 150 mg standardized flavonoid extract [5][7].
LDL Particle Quality: A 6-month prospective study (n=80) documented a significant redistribution of LDL subclasses: LDL-1 (large, buoyant) increased from 41.2% to 49.6% (p < 0.0001), while atherogenic small dense LDL-3, LDL-4, and LDL-5 all decreased significantly [6].
Subclinical Atherosclerosis: In the same cohort, carotid intima-media thickness (cIMT) decreased from 1.2 mm to 0.9 mm (p < 0.0001), suggesting potential anti-atherogenic effects beyond lipid modification [6].
Glycemic Control: In patients with concomitant hyperglycemia, BPF reduced fasting glucose by 18.9-22.4% (500-1,000 mg dose). The 2018 RCT confirmed glucose-lowering effects: BPF reduced glucose from 120 to 98 mg/dL, and BPF Phyto from 124 to 96 mg/dL [7].
Statin Potentiation: BPF 1,000 mg combined with rosuvastatin 10 mg produced lipid reductions comparable to rosuvastatin 20 mg alone, while also enhancing Akt/eNOS phosphorylation (an endothelial protective pathway not activated by rosuvastatin alone) [16].
Oxidative Protection: A 2024 RCT demonstrated significant reduction in ox-LDL (-2.0%) and increase in PON1 activity (+6.5%), supporting antioxidant and anti-atherogenic mechanisms in vivo [8].
When you're taking multiple supplements, it's hard to know which one is doing the heavy lifting. The benefits described above may overlap with effects from other items in your stack, lifestyle changes, or seasonal variation. Doserly helps you untangle that by keeping everything in one place, with timestamps, doses, and outcomes logged together.
Over time, this builds something more valuable than any product review: your personal evidence record. You can see exactly when you started this supplement, what else was in your routine at the time, and how your tracked health markers responded. That clarity makes the difference between guessing and knowing, whether you're talking to a healthcare provider or simply deciding if it's worth reordering.
Capture changes while they are still fresh.
Log symptoms, energy, sleep, mood, and other observations alongside protocol events so patterns do not live only in memory.
Trend view
Symptom timeline
Symptom tracking is informational and should be interpreted with a qualified clinician.
Side Effects & Safety
The Basics
One of bergamot extract's strengths is its safety profile. Across clinical trials lasting from 30 days to 6 months, bergamot has been consistently well tolerated. The most commonly reported side effect is mild heartburn (gastric pyrosis), which some participants noticed at higher doses but which was not severe enough to cause anyone to stop taking the supplement [7].
There are a few important considerations to keep in mind. Bergamot can lower blood sugar levels, which is beneficial for some people but potentially risky for those already taking diabetes medications, as it could cause blood sugar to drop too low. Anyone on glucose-lowering medications should discuss bergamot with their healthcare provider before starting [7].
Bergamot belongs to the citrus family, and like grapefruit, it may interact with certain medications by affecting drug metabolism. While the specific interactions are not as well documented as those for grapefruit, caution is warranted if you take medications that are known to interact with citrus compounds [1].
Some bergamot products contain furocoumarins (particularly bergapten), which can cause photosensitivity, making your skin more susceptible to sunburn. Many modern supplement formulations remove furocoumarins, but it is worth checking the product label, especially if you spend significant time outdoors [1].
There is limited safety data on bergamot use in pregnant or breastfeeding women, children, and older adults. These populations should exercise additional caution and consult a healthcare provider.
The Science
Clinical Trial Safety Data: In the largest clinical trial (n=237), moderate gastric pyrosis was reported in 6 patients receiving 500 mg BPF and 11 patients receiving 1,000 mg BPF. No patients discontinued treatment. Safety laboratory values (hepatic function, renal function, hematological parameters) were unchanged [7]. The 2024 RCT (n=64) confirmed that secondary endpoints (safety evaluation) showed no significant changes over 4 months, demonstrating good tolerability [8].
Blood Glucose Effects: Bergamot's hypoglycemic effects (18.9-22.4% fasting glucose reduction in hyperglycemic subjects) present a clinical consideration for patients on sulfonylureas, insulin, or other glucose-lowering agents. Monitoring of blood glucose is advisable when initiating bergamot supplementation in diabetic populations [7].
Hepatic Considerations: One anecdotal community report noted ALT elevation from 20 to 45 U/L after 30 days of bergamot supplementation. While isolated, this observation is not inconsistent with the hepatic metabolic effects of polyphenols at high concentrations. Clinical trials have not reported systematic hepatotoxicity, but periodic liver enzyme monitoring may be prudent for long-term use.
Phototoxicity: Bergamot essential oil is well documented for phototoxic reactions mediated by psoralen-containing compounds (bergapten/5-methoxypsoralen). Bergamot extract supplements typically contain much lower levels of these compounds than the essential oil, but users should verify that their supplement specifies furocoumarin-free or low-furocoumarin processing [1].
Drug Interactions: Bergamot contains furanocoumarins that inhibit CYP3A4, the same enzyme affected by grapefruit. Theoretically, bergamot could increase plasma concentrations of drugs metabolized by CYP3A4, including certain statins (simvastatin, lovastatin, atorvastatin), calcium channel blockers, and immunosuppressants. While clinical evidence for bergamot supplement interactions is limited, the pharmacological basis for concern exists [1].
Contraindications and Cautions:
- Diabetes medications (risk of hypoglycemia)
- CYP3A4-metabolized drugs (potential interaction)
- Pregnancy and lactation (insufficient safety data)
- Active liver disease (based on theoretical hepatic metabolic burden)
Managing side effect risks across a multi-supplement stack can feel overwhelming, especially when interactions between supplements, medications, and foods add layers of complexity. Doserly brings all of that into a single safety view so nothing falls through the cracks.
Rather than researching every possible interaction yourself, the app checks your full stack automatically and flags supplement-drug and supplement-supplement interactions that warrant attention. If you do experience something unexpected, logging it takes seconds, and over time the app helps you spot patterns: whether symptoms correlate with specific doses, timing, or combinations. One place for the safety picture that matters most when your stack grows beyond a few bottles.
Connect protocol changes to labs and health markers.
Doserly can keep lab results, biomarkers, symptoms, and dose history close together so follow-up conversations have better context.
Insights
Labs and trends
Doserly organizes data; it does not diagnose or interpret labs for you.
Dosing & Usage Protocols
The Basics
Bergamot extract dosing varies considerably across clinical trials, primarily because different products contain different concentrations of active compounds. The most commonly studied dose range is 500 to 1,500 mg per day of bergamot polyphenol fraction (BPF), standardized to 38% polyphenols. Some products use lower doses of more concentrated standardized flavonoid extracts (150 mg/day) [2][6][7].
Based on the clinical evidence, the effects appear to be dose-dependent. The largest clinical trial found that 1,000 mg daily produced substantially greater cholesterol reductions than 500 mg daily. Some practitioners recommend starting at the lower end and adjusting based on blood work results obtained after 30 to 90 days of consistent use [7].
For statin-intolerant individuals, the highest-dose regimen studied was 1,500 mg of BPF daily, which produced meaningful cholesterol reductions without the adverse effects associated with statin use [7].
Most clinical trials have administered bergamot before meals, typically once daily. Some protocols divide the dose into two servings (before breakfast and before dinner). The supplement appears to work most effectively when taken consistently for at least 30 days, with some benefits continuing to develop over 4 to 6 months of use [6][7][8].
The Science
Dosing from Clinical Trials:
Formulation
BPF (38% polyphenols)
- Daily Dose
- 500 mg
- Duration
- 30 days
- Key Findings
- TC -20%, LDL -23%
- Reference
- Mollace 2011 [7]
Formulation
BPF (38% polyphenols)
- Daily Dose
- 1,000 mg
- Duration
- 30 days
- Key Findings
- TC -30.9%, LDL -38.6%
- Reference
- Mollace 2011 [7]
Formulation
BPF (38% polyphenols)
- Daily Dose
- 1,500 mg
- Duration
- 30 days
- Key Findings
- TC -25%, LDL -27.6% (statin-intolerant)
- Reference
- Mollace 2011 [7]
Formulation
BPF + ascorbic acid 50 mg
- Daily Dose
- 1,000 mg
- Duration
- 30 days
- Key Findings
- Comparable to rosuvastatin 10 mg
- Reference
- Gliozzi 2013 [16]
Formulation
BPF (38% polyphenols)
- Daily Dose
- 1,300 mg (650 mg BID)
- Duration
- 30 days
- Key Findings
- TC 262→196, LDL 175→116
- Reference
- Mollace 2018 [7]
Formulation
BPF Phytosome
- Daily Dose
- 1,000 mg (500 mg BID)
- Duration
- 30 days
- Key Findings
- TC 261→198, LDL 174→113
- Reference
- Mollace 2018 [7]
Formulation
Standardized flavonoid extract
- Daily Dose
- 150 mg
- Duration
- 6 months
- Key Findings
- TC -12%, LDL -17%, cIMT reduced
- Reference
- Toth 2016 [6]
Formulation
Standardized flavonoid extract
- Daily Dose
- 150 mg
- Duration
- 4 months
- Key Findings
- TC -8.8%, LDL -11.5%
- Reference
- Nobile 2024 [8]
Timing: Clinical trials predominantly administered BPF 20-30 minutes before meals. The rationale relates to the interaction of polyphenols with dietary lipid metabolism and pCEH activity during postprandial processing [7][9].
Response Timeline: Lipid modifications are typically measurable within 30 days of consistent supplementation. The 6-month Toth study demonstrated continued improvements in LDL subclass distribution and cIMT reduction, suggesting progressive benefits with extended use [6].
When your stack includes several supplements, each with its own dose, form, and timing requirements, the logistics alone can derail consistency. Doserly consolidates all of it into one protocol view, so every dose across your entire routine is accounted for without spreadsheets or guesswork.
The app also tracks cumulative intake for nutrients that appear in multiple products. If your multivitamin, standalone supplement, and fortified protein shake all contain the same nutrient, Doserly adds them up and shows you the total alongside recommended and upper limits. Managing a thoughtful supplement protocol shouldn't require a degree in nutrition science. The app handles the complexity so you can focus on staying consistent.
Turn symptom and safety notes into a clearer timeline.
Doserly helps you log doses, symptoms, and safety observations side by side so patterns are easier to discuss with a qualified clinician.
Pattern view
Logs and observations
Pattern visibility is informational and should be reviewed with a clinician.
What to Expect (Timeline)
Weeks 1-2: Most people do not notice any subjective effects. Bergamot does not produce noticeable sensations in the way that caffeine or melatonin might. If you experience any heartburn, it typically appears during this initial period. Blood lipid levels are beginning to shift at the cellular level, but standard blood tests would not yet reflect meaningful changes.
Weeks 3-4: Some of the clinical trial data suggest lipid changes can become measurable by this point. One community report documented a 29% ApoB reduction in just 3 weeks, though this represents an unusually rapid and large response. Most people will not see changes this quickly. If you are also taking bergamot for blood sugar support, fasting glucose reductions have been documented within 30 days.
Months 1-3: This is the primary assessment window. The largest clinical trial (30 days) showed significant lipid changes by the one-month mark. Blood work at 30 to 90 days is the standard way to evaluate whether bergamot is working for you. The magnitude of change is highly individual; some people see dramatic reductions while others experience minimal change. If blood work shows no meaningful improvement after 90 days of consistent use, the supplement may not be effective for your particular metabolic profile.
Months 3-6: Continued improvement in lipid parameters and LDL particle quality has been documented at the 6-month mark. One study showed progressive reductions in carotid intima-media thickness over this timeframe, suggesting cardiovascular structural benefits that develop gradually. If bergamot is working, continued consistent use appears to offer sustained and potentially deepening benefits.
6+ Months: Long-term data beyond 6 months is limited. The clinical trials published to date do not extend beyond this timeframe. There are no established guidelines for cycling bergamot or taking breaks. Some community members report cycling (1 week off per month), though this practice is not based on clinical evidence.
Interactions & Compatibility
Synergistic
- Statins (Rosuvastatin): BPF 1,000 mg combined with rosuvastatin 10 mg produced lipid reductions comparable to rosuvastatin 20 mg alone, with enhanced endothelial protection [16]. Medical supervision essential.
- Vitamin C: Co-administered at 50 mg in several clinical trials as a stabilizer and potential synergist for antioxidant activity [7][16].
- L-Citrulline: A pilot study found synergistic effects of BPFG combined with L-citrulline on nitric oxide release, reactive hyperemia, and VO2 max in athletes [17].
- Fish Oil (EPA/DHA): Commonly stacked in community protocols for comprehensive lipid management. No interaction concerns identified.
- Berberine: Frequently stacked by community members for additive cholesterol-lowering effects. Both activate AMPK through different mechanisms. No formal interaction studies.
- CoQ10: Often paired as bergamot's statin-like mechanism may theoretically affect CoQ10 synthesis, though this has not been confirmed.
Caution / Avoid
- Simvastatin, Lovastatin, Atorvastatin: Bergamot contains furanocoumarins that may inhibit CYP3A4, potentially increasing plasma concentrations of CYP3A4-metabolized statins. This is the same mechanism as the grapefruit-drug interaction. Rosuvastatin and pitavastatin are minimally metabolized by CYP3A4 and are less likely to interact [1].
- Diabetes Medications (Sulfonylureas, Insulin): Bergamot's glucose-lowering effects (up to 22% fasting glucose reduction) may potentiate hypoglycemia risk when combined with glucose-lowering medications [7].
- Calcium Channel Blockers: Theoretical CYP3A4-mediated interaction based on furocoumarin content [1].
- Immunosuppressants (Cyclosporine, Tacrolimus): Theoretical CYP3A4-mediated interaction [1].
- Anticoagulants: No specific data, but caution warranted due to polyphenol effects on platelet function.
How to Take / Administration Guide
Recommended forms: Most clinical evidence supports bergamot polyphenol fraction (BPF) standardized to approximately 38% total polyphenols, typically delivered in capsule form. Standardized flavonoid extracts at lower doses (150 mg/day) have also shown efficacy in clinical trials. Phytosome formulations may offer enhanced bioavailability.
Timing considerations: Based on clinical trial protocols, bergamot is typically taken 20 to 30 minutes before a meal. Most studies used once-daily dosing before the largest meal, though some protocols divide the dose into two servings (morning and evening, each before a meal). Taking bergamot with food does not appear harmful but may reduce the interaction with dietary lipid processing that is part of its proposed mechanism.
Stacking guidance: Bergamot is frequently combined with other lipid-supporting supplements including fish oil, berberine, and plant sterols. When using alongside statins, rosuvastatin or pitavastatin are preferred over simvastatin, lovastatin, or atorvastatin due to the potential CYP3A4 interaction. Always discuss statin-bergamot combinations with a healthcare provider.
Cycling guidance: No formal cycling protocols have been established in clinical research. Some community members report cycling (2 days off per week or 1 week off per month), but this is not evidence-based. The clinical trials used continuous daily dosing for 30 days to 6 months without prescribed breaks.
Choosing a Quality Product
Third-party certifications: Look for supplements with USP Verified, NSF Certified for Sport, or GMP certification. These programs verify identity, potency, and purity of ingredients.
Active forms to look for: BPF standardized to 38% polyphenols is the most clinically studied formulation. Products specifying the marker compounds neoeriocitrin, naringin, and neohesperidin provide additional quality assurance. The patented Bergamonte extract is the formulation used in multiple clinical trials.
Red flags:
- Products that do not specify polyphenol standardization percentage
- "Bergamot oil" products (essential oil, not the polyphenol extract used in clinical studies)
- Proprietary blends that hide the actual bergamot extract dose
- Products claiming to contain bergamot without specifying the extract type (juice, peel, whole fruit)
- Unusually low-priced products with no standardization information
Furocoumarin content: Products that specify furocoumarin-free or bergapten-free processing are preferable, particularly for individuals who spend significant time in sunlight or who take medications metabolized by CYP3A4.
Excipient considerations: Standard capsule excipients (cellulose, silica, magnesium stearate) are typical. Most bergamot supplements are naturally free of common allergens (gluten, dairy, soy).
Storage & Handling
Store bergamot extract in a cool, dry place away from direct sunlight and heat. Room temperature storage (59-77 degrees F / 15-25 degrees C) is appropriate for most products. Keep the container tightly sealed between uses. Polyphenols can degrade when exposed to heat, moisture, and light, so proper storage protects the potency of the active compounds. There are no special refrigeration requirements for standard capsule formulations. Follow the expiration date on the product label.
Lifestyle & Supporting Factors
Diet: Bergamot extract works best as part of a heart-healthy dietary pattern. Reducing saturated fat intake and increasing soluble fiber (oats, beans, psyllium) have additive effects on cholesterol reduction. Mediterranean-style diets, rich in olive oil, fish, and vegetables, align well with the cardiovascular goals of bergamot supplementation.
Exercise: Regular aerobic exercise independently improves lipid profiles by raising HDL and modestly lowering LDL. Combining bergamot with consistent physical activity may enhance overall cardiovascular outcomes.
Monitoring: Blood lipid panels are the primary way to assess whether bergamot is working. A baseline test before starting supplementation, followed by a retest at 30 to 90 days, provides the data needed to evaluate individual response. Full lipid panels (TC, LDL, HDL, TG), and ideally ApoB and LDL particle size testing, give the most complete picture.
Weight management: Excess body weight is a significant contributor to dyslipidemia. Weight loss through diet and exercise can amplify the benefits of bergamot supplementation. However, note that rapid weight loss can temporarily spike LDL levels before they normalize.
Alcohol: Excessive alcohol consumption raises triglyceride levels and counteracts the cardiovascular benefits of any supplement regimen. Moderate or minimal alcohol intake supports lipid management goals.
Regulatory Status & Standards
United States (FDA): Bergamot extract is marketed as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA). It is not approved as a drug for the treatment of any disease. Supplements may not legally claim to diagnose, treat, cure, or prevent any disease. Bergamot extract does not have GRAS (Generally Recognized as Safe) status as a standalone ingredient, though citrus-derived flavonoids have a long history of dietary use.
Canada (Health Canada): Bergamot-containing products may be sold as Natural Health Products (NHPs) with appropriate NPN registration and compliance with monograph requirements.
European Union (EFSA): Citrus polyphenol extracts are available as food supplements. EFSA has not issued specific authorized health claims for bergamot polyphenols. The ESC Working Group on Cardiovascular Pharmacotherapy has acknowledged bergamot as a promising nutraceutical for lipid management in a 2020 expert opinion paper, while noting that further research is needed.
Australia (TGA): Bergamot extract may be available as a listed complementary medicine subject to TGA requirements.
Athlete & Sports Regulatory Status:
- WADA: Bergamot extract does not appear on the WADA Prohibited List. Citrus polyphenols are not classified as prohibited substances.
- National Anti-Doping Agencies: No specific guidance or alerts have been issued by USADA, UKAD, Sport Integrity Canada, Sport Integrity Australia, or NADA Germany regarding bergamot extract.
- Professional Sports Leagues: No league-specific restrictions on bergamot extract have been identified for NFL, NBA, MLB, NHL, MLS, or NCAA.
- Athlete Certification Programs: Athletes should look for products tested by Informed Sport, NSF Certified for Sport, or Cologne List programs to minimize contamination risk. Certified bergamot products are available from some manufacturers.
- GlobalDRO: Athletes can verify the status of bergamot supplements via GlobalDRO.com for US, UK, Canada, Australia, Japan, Switzerland, and New Zealand.
Regulatory status and prohibited substance classifications change frequently. Athletes should always verify the current status of any supplement with their sport's governing body, their national anti-doping agency, and a qualified sports medicine professional before use. Third-party certification (Informed Sport, NSF Certified for Sport) reduces but does not eliminate the risk of contamination with prohibited substances.
Frequently Asked Questions
Can bergamot extract replace statin medications?
Based on available data, bergamot extract has shown cholesterol-lowering effects in clinical trials, but it is not established as a replacement for statin medications. Statins have decades of evidence demonstrating reductions in cardiovascular events, heart attacks, and mortality. Bergamot has not been studied for these clinical endpoints. Some individuals who cannot tolerate statins have used bergamot as an alternative under medical supervision, but this decision should be made with a qualified healthcare provider.
What dose of bergamot extract is most commonly studied?
Clinical trials have used doses ranging from 150 mg of standardized flavonoid extract to 1,500 mg of bergamot polyphenol fraction (BPF) daily. The most commonly cited range for BPF is 500 to 1,000 mg per day, standardized to 38% polyphenols. Effects appear to be dose-dependent, with higher doses producing larger cholesterol reductions in clinical trials.
How long does it take for bergamot to affect cholesterol levels?
Clinical trials have documented measurable changes in blood lipid levels within 30 days of consistent daily supplementation. Some benefits, including improvements in LDL particle quality and carotid intima-media thickness, have been observed to develop progressively over 4 to 6 months.
Is bergamot extract the same as bergamot essential oil?
No. Bergamot extract (BPF) is derived from the juice, pith, and rind of the bergamot fruit and is standardized for polyphenol content. Bergamot essential oil is extracted from the peel and is primarily composed of volatile aromatic compounds (linalool, linalyl acetate, limonene). The essential oil is used in aromatherapy and perfumery, while the polyphenol extract is the form studied for cardiovascular health benefits.
Can I take bergamot extract with my statin medication?
Some clinical research has examined the combination of bergamot with rosuvastatin and found it to be safe and potentially synergistic over 30 days. However, bergamot contains furanocoumarins that may interact with certain statins metabolized by the CYP3A4 enzyme (simvastatin, lovastatin, atorvastatin). Rosuvastatin and pitavastatin are less affected. Always consult your healthcare provider before combining bergamot with any prescription medication.
Does bergamot affect blood sugar?
Yes. Clinical trials have documented fasting glucose reductions of 19 to 22% in people with elevated blood sugar who took bergamot polyphenol fraction. This effect is relevant for individuals with prediabetes or metabolic syndrome, but it also means that people on diabetes medications should use bergamot cautiously due to the risk of hypoglycemia.
Is bergamot safe for long-term use?
The longest published clinical trial ran for 6 months and reported no significant safety concerns. However, long-term data beyond this period is limited. There are no established guidelines for maximum duration of use. Periodic liver function testing may be prudent for long-term supplementation.
Why do some people not respond to bergamot?
Individual response to bergamot varies considerably. Some people see large cholesterol reductions while others see minimal change or even increases. Factors that may influence response include baseline lipid levels, genetic variations in cholesterol metabolism, the specific bergamot product used (standardization and quality vary), and concurrent dietary and lifestyle factors. People with familial hypercholesterolemia, which is caused by genetic mutations, may be less responsive to bergamot supplementation.
Does bergamot cause photosensitivity?
Bergamot essential oil contains furanocoumarins (bergapten) that cause phototoxic reactions. Bergamot polyphenol extract supplements typically contain much lower levels of these compounds. Products labeled as furocoumarin-free or bergapten-free have been processed to remove these phototoxic components. If your product does not specify removal of these compounds, using sun protection is advisable.
Can I get the same benefits from drinking Earl Grey tea?
Earl Grey tea is flavored with bergamot essential oil, not bergamot polyphenol extract. The amount of polyphenols in a cup of Earl Grey tea is negligible compared to the doses used in clinical trials (150-1,500 mg of concentrated extract). Drinking Earl Grey tea is not a substitute for bergamot polyphenol supplementation.
Myth vs. Fact
Myth: Bergamot extract works exactly like a statin drug.
Fact: While two compounds in bergamot (brutieridin and melitidin) have structural similarities to statins, definitive evidence that bergamot directly inhibits HMG-CoA reductase in the same manner as statins has not been established. Bergamot appears to work through multiple mechanisms including AMPK activation, pCEH inhibition, and antioxidant effects, which are distinct from the primary statin pathway [1][3][11].
Myth: All bergamot supplements are the same.
Fact: Bergamot products vary significantly in their polyphenol content, standardization, and active compound profiles. Bergamot essential oil (used in aromatherapy and Earl Grey tea) is completely different from bergamot polyphenol fraction (BPF), which is the form studied for cholesterol effects. Products should specify their polyphenol standardization (typically 38% for BPF) and ideally identify the marker compounds present [1][6][7].
Myth: Bergamot can cure high cholesterol.
Fact: Bergamot extract has demonstrated cholesterol-lowering effects in clinical trials, but it has not been shown to reduce cardiovascular events, heart attacks, or death. Lowering LDL cholesterol is an important goal, but bergamot's clinical evidence base is limited to biomarker changes over short to moderate durations (30 days to 6 months). Statins, by contrast, have outcome data spanning decades [2][5].
Myth: Bergamot is unsafe because it is related to grapefruit.
Fact: While bergamot does contain furanocoumarins similar to those in grapefruit that can affect drug metabolism, the concentrations in supplement form are generally much lower than in grapefruit juice. Many supplement manufacturers specifically remove furocoumarins during processing. The interaction risk is most relevant for CYP3A4-metabolized medications, and not all statins are affected equally (rosuvastatin and pitavastatin have minimal CYP3A4 involvement) [1].
Myth: Everyone responds to bergamot supplementation.
Fact: Individual variability in response to bergamot is well documented both in clinical trials and community reports. Some users experience dramatic lipid improvements while others see minimal change. Factors including genetics, baseline lipid levels, metabolic profile, and product quality all influence outcomes. A 30 to 90-day trial with blood work monitoring is the most reliable way to determine individual response [2][7].
Myth: Higher doses of bergamot are always better.
Fact: While the clinical data shows a dose-dependent response, the relationship is not unlimited. The largest trial showed diminishing returns at the highest dose tested (1,000 mg vs. 500 mg showed a roughly 50% greater effect, but 1,500 mg in statin-intolerant patients showed less reduction than 1,000 mg in the general population). Higher doses also increase the likelihood of gastrointestinal side effects. Starting at a moderate dose and adjusting based on blood work results is a more prudent approach [7].
Sources & References
Clinical Trials & RCTs
[1] Nauman MC, Johnson JJ. Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers. Integr Food Nutr Metab. 2019;6(2):10.15761/IFNM.1000249. PMC6497409.
[2] Lamiquiz-Moneo I, et al. Effect of bergamot on lipid profile in humans: A systematic review. Crit Rev Food Sci Nutr. 2020;60(18):3133-3143. PMID: 31670973.
[3] Di Donna L, et al. Statin-like principles of bergamot fruit (Citrus bergamia): isolation of 3-hydroxymethylglutaryl flavonoid glycosides. J Nat Prod. 2009;72(7):1352-4. PMID: 19572741.
[4] Osadnik T, et al. A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. Pharmacol Res. 2022;183:106402. DOI: 10.1016/j.phrs.2022.106402.
[5] Sadeghi-Dehsahraei H, et al. The effect of bergamot (KoksalGarry) supplementation on lipid profiles: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022;36:4409-4424. PMID: 36251526.
[6] Toth PP, et al. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study. Front Pharmacol. 2015;6:299. PMC4680381.
[7] Mollace V, et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia. 2011;82(3):309-16. PMID: 21056640. Also: Mollace V, et al. Hypoglycemic and hypolipemic effects of a new lecithin formulation of bergamot polyphenolic fraction: a double blind, randomized, placebo-controlled study. Endocr Metab Immune Disord Drug Targets. 2019;19(2):136-143. PMID: 30501605.
[8] Nobile V, et al. Citrus bergamia Extract, a Natural Approach for Cholesterol and Lipid Metabolism Management: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. Foods. 2024;13(23):3883. PMID: 39682955.
[9] Musolino V, et al. Lipid-lowering effect of bergamot polyphenolic fraction: role of pancreatic cholesterol ester hydrolase. J Biol Regul Homeost Agents. 2017;31(4):1087-93. PMID: 29254318.
[10] Sui GG, et al. Naringin Activates AMPK Resulting in Altered Expression of SREBPs, PCSK9, and LDLR To Reduce Body Weight in Obese C57BL/6J Mice. J Agric Food Chem. 2018;66(34):8983-90. PMID: 30080974.
[11] Leopoldini M, et al. On the inhibitor effects of bergamot juice flavonoids binding to the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme. J Agric Food Chem. 2010;58(19):10768-73. PMID: 20825153.
Observational Studies
[12] Yu J, et al. Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J Agric Food Chem. 2005;53(6):2009-14. PMID: 15769128.
[13] Risitano R, et al. Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-kappaB inhibition in THP-1 monocytes. PLoS One. 2014;9(9):e107431. PMC4177872.
[14] Mollace V, et al. The protective effect of bergamot oil extract on lecitine-like oxyLDL receptor-1 expression in balloon injury-related neointima formation. J Cardiovasc Pharmacol Ther. 2008;13(2):120-9. PMID: 18525087.
[15] Mollace R, et al. The second life of Citrus bergamia: bioavailability analysis of a new formulation. PubMed. 2025. PMID: 40707768.
Government/Institutional Sources
[16] Gliozzi M, et al. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. Int J Cardiol. 2013;170(2):140-5. PMID: 24239156.
[17] Mollace R, et al. The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study. PubMed. 2025. PMID: 40218864.
Related Supplement Guides
Same Category
Common Stacks / Pairings
- Fish Oil (EPA/DHA)
- CoQ10 (not yet in registry as standalone)
- L-Citrulline
- Vitamin C
- NAC
Related Health Goal
- Red Yeast Rice (not in registry)
- Berberine (not in registry as standalone)
- Niacin (Vitamin B3)
- Flaxseed Oil
- Olive Leaf (not in registry)